Figure 1. VALIANT Study: Combined end-point (cardiovascular death, myocardial infarction and heart failure). Valsartan vs. Captopril: HR = 0.96; P = 0.198; Valsartan + Captopril vs. Captopril: HR = 0.97; P = 0.369. (Adapted with permission from Pfeffer et al)11